sotorasib
amgen
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'crcsm', 'nsclc', 'codebreak100', 'biomarker', 'sclc']
plasma biomarker analysis of codebreak100. talk by dr. bob t li #crcsm #asco22
1st nsclc:
2nd crc: 75% of pts had acquired mutations at progression, 16/100 new mutations were actionable 
Pt Adv, NCI Rectal Anal TF
Mom, lifelong learner
Wants to bring patient voice to research, clinical trials & more!
Check out @CRCTrialsChat
1st love: Virology